scholarly journals ‘No-one is Safe Until Everyone is Safe’ – Patent Waiver, Compulsory Licensing and COVID-19

2021 ◽  
Vol 5 (2) ◽  
pp. 71-91
Author(s):  
B. Kianzad ◽  
J. Wested
Keyword(s):  
Compulsory Licensing

How Much Time Before Attempting Compulsory Licensing of Pharmaceuticals? A Non-parametric Event History Model With P-splines

2018 ◽  
Vol 49 (1) ◽  
pp. 68-84
Author(s):  
Kyung-Bok Son
Keyword(s):  
Intellectual Property ◽  
Global Justice ◽  
Learning By Doing ◽  
Event History ◽  
Global Marketing ◽  
Compulsory Licensing ◽  
Country Level ◽  
The Difference ◽  
Justice Movements ◽  
Doha Declaration

Compulsory licensing (CL), provided by the Agreement on Trade-Related Aspects of Intellectual Property Rights, enables countries, including high-income countries, to ensure the protection of public health in the context of stringent intellectual property regimes. This study investigated associations between the time to attempted CL and a series of factors at the drug and country level. We used a dataset of all attempted CL that occurred from 1995 to 2014, calculated the duration as the difference in years between the year of global marketing of a certain drug and the year of attempted CL in a certain country, and applied a nonparametric event history model. We found that the Doha Declaration was quite effective in shortening the time to attempted CL. Additionally, even though global justice movements have encouraged some countries to attempt CL for various medicines since 2012, the time to CL attempts in this period became significantly longer compared to those that occurred immediately after the Doha Declaration. Our findings show that the subject of CL has not successfully expanded to oncology medicines from HIV/AIDS medicines and that recently approved medicines are not yet subjects of CL. Furthermore, our duration model suggests a learning-by-doing effect in attempting CL: previous experience of CL not only triggers CL for the same drugs in other countries but also accelerates CL for other drugs within the country.

scholarly journals Compulsory Licensing Often Did Not Produce Lower Prices For Antiretrovirals Compared To International Procurement

2015 ◽  
Vol 34 (3) ◽  
pp. 493-501 ◽  
Author(s):  
Reed F. Beall ◽  
Randall Kuhn ◽  
Amir Attaran
Keyword(s):  
Compulsory Licensing
Sign in / Sign up

Export Citation Format

Share Document